Przedborski S - Search Results

1

Petzinger G, Mayer SA, Przedborski S. Petzinger G, et al. Among authors: przedborski s. Mov Disord. 1995 Sep;10(5):679-80. doi: 10.1002/mds.870100526. Mov Disord. 1995. PMID: 8552126 No abstract available.

2

The parkinsonian toxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): a technical review of its utility and safety.

Przedborski S, Jackson-Lewis V, Naini AB, Jakowec M, Petzinger G, Miller R, Akram M. Przedborski S, et al. J Neurochem. 2001 Mar;76(5):1265-74. doi: 10.1046/j.1471-4159.2001.00183.x. J Neurochem. 2001. PMID: 11238711 Free article. Review. No abstract available.

3

Delayed-onset dyskinesias.

Przedborski S, Kostic VN, Burke RE. Przedborski S, et al. Neurology. 1996 Nov;47(5):1358-9. doi: 10.1212/wnl.47.5.1358-a. Neurology. 1996. PMID: 8909476 No abstract available.

4

Induction of mania by apomorphine in a depressed parkinsonian patient.

Przedborski S, Liard A, Hildebrand J. Przedborski S, et al. Mov Disord. 1992;7(3):285-7. doi: 10.1002/mds.870070318. Mov Disord. 1992. PMID: 1620150 No abstract available.

5

Antiparkinsonian therapies and brain mitochondrial complex I activity.

Przedborski S, Jackson-Lewis V, Fahn S. Przedborski S, et al. Mov Disord. 1995 May;10(3):312-7. doi: 10.1002/mds.870100314. Mov Disord. 1995. PMID: 7651449

6

Pathogenic role of glial cells in Parkinson's disease.

Teismann P, Tieu K, Cohen O, Choi DK, Wu DC, Marks D, Vila M, Jackson-Lewis V, Przedborski S. Teismann P, et al. Among authors: przedborski s. Mov Disord. 2003 Feb;18(2):121-9. doi: 10.1002/mds.10332. Mov Disord. 2003. PMID: 12539204 Review.

7

Peripheral and central pharmacokinetics of apomorphine and its effect on dopamine metabolism in humans.

Przedborski S, Levivier M, Raftopoulos C, Naini AB, Hildebrand J. Przedborski S, et al. Mov Disord. 1995 Jan;10(1):28-36. doi: 10.1002/mds.870100107. Mov Disord. 1995. PMID: 7885353

8

Alpha-synuclein up-regulation in substantia nigra dopaminergic neurons following administration of the parkinsonian toxin MPTP.

Vila M, Vukosavic S, Jackson-Lewis V, Neystat M, Jakowec M, Przedborski S. Vila M, et al. Among authors: przedborski s. J Neurochem. 2000 Feb;74(2):721-9. doi: 10.1046/j.1471-4159.2000.740721.x. J Neurochem. 2000. PMID: 10646524 Free article.

9

Oxidative post-translational modifications of alpha-synuclein in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) mouse model of Parkinson's disease.

Przedborski S, Chen Q, Vila M, Giasson BI, Djaldatti R, Vukosavic S, Souza JM, Jackson-Lewis V, Lee VM, Ischiropoulos H. Przedborski S, et al. J Neurochem. 2001 Jan;76(2):637-40. doi: 10.1046/j.1471-4159.2001.00174.x. J Neurochem. 2001. PMID: 11208927 Free article.

10

Protocol for the MPTP mouse model of Parkinson's disease.

Jackson-Lewis V, Przedborski S. Jackson-Lewis V, et al. Among authors: przedborski s. Nat Protoc. 2007;2(1):141-51. doi: 10.1038/nprot.2006.342. Nat Protoc. 2007. PMID: 17401348

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

278 results

Search Page

Filters